Lower levels of cortical [
Cortex
Muscarinic M1 receptor
Schizophrenia
Sub-group
Symptom ratings
Journal
Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
07
07
2022
revised:
15
02
2023
accepted:
18
03
2023
medline:
15
5
2023
pubmed:
20
4
2023
entrez:
20
04
2023
Statut:
ppublish
Résumé
Multiple lines of evidence argue for lower levels of cortical muscarinic M1 receptors (CHRM1) in people with schizophrenia which is possibly due to a sub-group within the disorder who have a marked loss of CHRM1 (muscarinic receptor deficit sub-group (MRDS)). In this study we sought to determine if the lower levels of CHRM1 was apparent in older people with schizophrenia and whether the loss of CHRM1 was associated with symptom severity by measuring levels of cortical [
Identifiants
pubmed: 37079947
pii: S0920-9964(23)00129-9
doi: 10.1016/j.schres.2023.03.035
pii:
doi:
Substances chimiques
Pirenzepine
3G0285N20N
Receptor, Muscarinic M1
0
CHRM1 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
274-282Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest BD, VF and ES have no conflicts of interest.